Cancer Research UK and 50 leaders from across the NHS and cancer community have authored a letter to the Prime Minister and first Ministers in Scotland and Wales, and First and Deputy First Ministers of Northern Ireland to fight for cancer care and research. The...
Cancer Research UK
NCI & Cancer Research UK Partner to Drive Innovate New Cancer Research
In what can only be considered an exciting move in the world of cancer research, the United States’ national research institute—the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), formed a partnership with the United Kingdom’s Cancer...
Cancer Research UK Edinburgh Unfortunately Faces Severe Reality Due to COVID-19
Cancer Research UK Edinburgh placed all but one of its cancer clinical research studies on hold during the pandemic, reports Professor Charlie Gourley, its clinical director. With the greenlight to now proceed with seven clinical trials, the ovarian cancer expert...
Cancer Research UK Calls for Action to Boost Wide-Spread British Testing to Save Cancer Patients due to COVID-19 Disruptions
The COVID-19 pandemic has endangered the lives of thousands of cancer patients in the United Kingdom (UK). Consequently, Cancer Research UK is calling for widespread testing to anticipate and prevent unnecessary cancer deaths. Will a triage system essentially lead to...
Cancer UK Partners with Start Codon Targeting the Cambridge Cluster for Life Science Startup Investment
Cancer Research UK’s Entrepreneurial Programmes Initiative includes a new partner; life science and healthcare business accelerator Start Codon now has teamed up to help promote the development of new business ventures within academia. The Cambridge, UK cluster will...
Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund a Phase I/IIa Clinical Trial as First-Line NSCLC Therapy
Vaccitech Ltd announced today, December 18th, 2019, that its strategic collaboration with the Ludwig Institute for Cancer Research (Ludwig), Vaccitech Oncology Limited (VOLT), has entered into a clinical partnership with Cancer Research UK to develop VOLT’s VTP-600...
University of Glasgow Moving into the Forefront of Pancreatic Cancer Research
Cancer Research UK is investing £10m in a pancreatic clinical research project to identify ways to accelerate scientific discovery and improve survival rates of these cancer patients. The bulk of the funds, £8m, will go to investigators at Glasgow University. Because...
Looking for Earliest Stages of Cancer Leads to Radically Innovative Research by International Alliance
Understanding the biology of early cancers and pre-cancerous states will allow doctors to find accurate ways to spot the disease earlier and where necessary treat it effectively. It could even enable "precision prevention" - where the disease could be stopped from...
Personalised Breast Cancer Programme (PBCP) in UK Using Gene Analysis to Potentially Guide Treatment Decisions
Dr Jean Abraham co-leads the Personalised Breast Cancer Programme (PBCP), a collaboration between Cancer Research UK and Addenbrooke’s Charitable Trust. It has analysed the genes of 600 breast cancer patients to see if they could do this quickly enough to use the...
Imperial College London & Institute of Cancer Research Launch New £13m Convergence Science Centre
The Imperial College of London and the Institute of Cancer Research UK has launched the new £13 million Convergence Science Centre, bringing together researchers from different scientific disciplines to develop a range of innovative cancer techniques. The Principals...